C 31 H 36 F 2 N 6 S, monoclinic, P21/c (no. 14), a = 14.7561 (8) 
contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters. . 
(C = S). ESI-MS, m/z: 563 [M+H]
+ .
Discussion
Derivatives of adamantane have long been known for their antiviral activity against the in uenza A [1] [2] [3] [4] , herpes simplex [5] and HIV [6] [7] [8] viruses. Several adamantane-based drugs are currently used as e cient therapies for the control central nervous disorders [9] [10] [11] [12] . In addition, potent antimicrobial [13] [14] [15] [16] [17] [18] , anti-in ammatory [16] [17] [18] and anticancer [19, 20] activities were reported for adamantane-based derivatives. 1,2,4-Triazole derivatives were also recognized as a structural motif of particular value in medicinal chemistry possessing diverse biological activities [21] [22] [23] . In the present study, we report the crystal structure together with the synthesis of the title 1,2,4-triazole-N-Mannich base which was reported to exhibit marked antifungal activity [17] . This contribution is part of study on admantyl-based drugs [24] There is one complete molecule in the asymmetric unit of the title structure. All bond lengths and angels are in the expected ranges.
The molecules packing in the crystal structure is stabilized via two intermolecular hydrogen bonds, of which S1 and F2 work as hydrogen bond acceptors and C14 and C15 work as hydrogen bond donors. The distance of the interactions between C14-H14B· · · S1
i and C15-H15A· · · F2 i are 2.85 and 2.54 Å, respectively and the angles are 135 and 130°, respectively. Symmetry codes: (i) −x+2, −y+1, −z.
